As of 2025, Santen Pharmaceutical has disclosed 4 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 4 absolute reduction targets, signaling the company's commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Santen Pharmaceutical's climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Absolute-based Target* | Scope 3 - Purchased Goods and Services (Cat. 1) | Metric Tonnes of CO2 equivalent (mtCO2e) | -8%a | 2025 |
Absolute-based Target | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | -25%b | 2025 |
Absolute-based Target* | Scope 3 - Purchased Goods and Services (Cat. 1) | Metric Tonnes of CO2 equivalent (mtCO2e) | -15%a, b | 2030 |
Absolute-based Target | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | -50%b | 2030 |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
As of 2025, Santen Pharmaceutical has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint.ab
As of 2025, Santen Pharmaceutical has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.b
Santen Pharmaceutical's most ambitious operational target is to reduce these emissions by 50% by 2030, compared to a baseline of 37,529 Metric Tonnes of CO2 equivalent (mtCO2e) in 2019.b
As of 2024, Santen Pharmaceutical is lagging behind on its operational emissions reduction target, having achieved 14.18% of the planned reduction.b
As of 2025, Santen Pharmaceutical has set a target to reduce its value chain greenhouse gas (GHG) emissions, covering 1 out of the 15 Scope 3 categories defined by the GHG Protocol.ab
Santen Pharmaceutical's most ambitious value chain target is to reduce these emissions by 15% by 2030, compared to a baseline of 114,613 Metric Tonnes of CO2 equivalent (mtCO2e) in 2019.ab
Santen Pharmaceutical has already surpassed its value chain emissions reduction target, with 2024 levels falling below the 2030 value, achieving its climate goal ahead of schedule.ab